Chronic Kidney Disease Is a Risk Factor for the Development of Hyperchloremic Metabolic Acidosis After Repeated Therapeutic Plasma Exchanges
Journal of Clinical Apheresis · 2025
DOI: 10.1002/jca.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Apheresis, 2025. Verfasst von Sanédy Sa Simon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Acidosis, Renal Insufficiency, Chronic, Plasma Exchange. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hyperchloremic metabolic acidosis is an underreported but common metabolic complication following therapeutic plasma exchange (TPE) with an albumin‐saline solution, particularly when multiple TPE sessions are performed within a limited period. The risk of hyperchloremic metabolic acidosis may be the highest in patients with chronic kidney disease because of their limited acid excretion capacity. We prospectively collected data from all patients who received TPE at Amsterdam UMC between February 2023 and March 2025. We collected data on demographics, TPE‐related parameters, and blood electrolyte concentrations. We investigated the effect of TPE on plasma sodium, chloride, and bicarbonate concentrations, the occurrence of adverse events, and the modulating role of kidney function. Data from 64 patients with 320 TPE sessions were included in the analysis. The mean age was 50 years, 55% of the patients were male and the mean eGFR was 35 mL/min/1.73 m 2 . The effect of a single TPE on plasma electrolyte concentration was independent of kidney function. However, after multiple TPE sessions, a lower eGFR was associated with a greater increase in plasma chloride concentration ( p < 0.001) and a larger decrease in plasma bicarbonate concentration ( p < 0.001) despite oral bicarbonate supplementation and a lower baseline plasma bicarbonate concentration. Patients with a lower eGFR were more likely to experience adverse events during a TPE session ( p = 0.004). Chronic kidney disease is a risk factor for developing hyperchloremic metabolic acidosis and adverse events during an intensive TPE cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Cardiovascular Sciences, Diabetes and Hypertensive Diseases, Amsterdam UMC, Amsterdam, the Netherlands.
- Dianet Dialysis Centre, Amsterdam, the Netherlands.
ORCID-Profile: Sanédy Sa Simon, Rik H Olde Engberink
Zitieren
APA
Simon, S. S., van Sandwijk, M. S., & Olde Engberink, R. H. (2025). Chronic Kidney Disease Is a Risk Factor for the Development of Hyperchloremic Metabolic Acidosis After Repeated Therapeutic Plasma Exchanges. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70059
Vancouver
Simon SS, van Sandwijk MS, Olde Engberink RH. Chronic Kidney Disease Is a Risk Factor for the Development of Hyperchloremic Metabolic Acidosis After Repeated Therapeutic Plasma Exchanges. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70059
BibTeX
@article{Simon2025,
author = {Simon, Sanédy Sa and van Sandwijk, Marit S and Olde Engberink, Rik H},
title = {Chronic Kidney Disease Is a Risk Factor for the Development of Hyperchloremic Metabolic Acidosis After Repeated Therapeutic Plasma Exchanges},
journal = {Journal of Clinical Apheresis},
year = {2025},
doi = {10.1002/jca.70059}
}
EUVIMED